Primary Care for HIV-Infected Patients in Resource-Limited Settings

  • Authors: Charles van der Horst, MD; F. Parker Hudson, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • Patient follow-up during ART must include assessment of weight, clinical response to therapy, signs/symptoms of potential toxicity, and adherence[WHO ART]
  • WHO recommends that laboratory monitoring be available for patients receiving ART, in addition to directed clinical monitoring to diagnose hepatitis, anemia (for patients receiving zidovudine), renal dysfunction (for patients receiving tenofovir DF), and liver dysfunction (for patients receiving nevirapine) (Table 6)[WHO ART]
  • WHO recommends HIV-1 RNA monitoring every 6-12 months, where available[WHO ART]

Action required